Aldehyde‐Based Inhibitors of the Peptidoglycan O‐Acetylesterase Ape
The O‐acetylation of the muramic acid residues in peptidoglycan (PG) is a modification that protects the bacteria from lysis due to the action of lysozyme. In Gram‐negative bacteria, deacetylation is required to allow lytic transglycosylases to promote PG cleavage during cell growth and division. Th...
Saved in:
Published in: | Chembiochem : a European journal of chemical biology Vol. 24; no. 11; pp. e202300205 - n/a |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Germany
Wiley Subscription Services, Inc
01-06-2023
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | The O‐acetylation of the muramic acid residues in peptidoglycan (PG) is a modification that protects the bacteria from lysis due to the action of lysozyme. In Gram‐negative bacteria, deacetylation is required to allow lytic transglycosylases to promote PG cleavage during cell growth and division. This deacetylation is catalyzed by O‐acetylpeptidoglycan esterase (Ape) which is a serine esterase and employs covalent catalysis via a serine‐linked acyl enzyme intermediate. Loss of Ape activity affects the size and shape of bacteria and dramatically reduces virulence. In this work, we report the first rationally designed aldehyde‐based inhibitors of Ape from Campylobacter jejuni. The most potent of these acts as a competitive inhibitor with a Ki value of 13 μM. We suspect that the inhibitors are forming adducts with the active site serine that closely mimic the tetrahedral intermediate of the normal catalytic cycle. Support for this notion is found in the observation that reduction of the aldehyde to an alcohol effectively abolishes the inhibition.
Aldehyde‐based inhibitors of the peptidoglycan deacetylase Ape were shown to act as competitive inhibitors with Ki values in the low micromolar range. Reduction of the aldehyde to an alcohol abolishes inhibition, suggesting that the binding may involve the formation of a tetrahedral adduct with the active site serine nucleophile. |
---|---|
AbstractList | The O‐acetylation of the muramic acid residues in peptidoglycan (PG) is a modification that protects the bacteria from lysis due to the action of lysozyme. In Gram‐negative bacteria, deacetylation is required to allow lytic transglycosylases to promote PG cleavage during cell growth and division. This deacetylation is catalyzed by O‐acetylpeptidoglycan esterase (Ape) which is a serine esterase and employs covalent catalysis via a serine‐linked acyl enzyme intermediate. Loss of Ape activity affects the size and shape of bacteria and dramatically reduces virulence. In this work, we report the first rationally designed aldehyde‐based inhibitors of Ape from Campylobacter jejuni. The most potent of these acts as a competitive inhibitor with a Ki value of 13 μM. We suspect that the inhibitors are forming adducts with the active site serine that closely mimic the tetrahedral intermediate of the normal catalytic cycle. Support for this notion is found in the observation that reduction of the aldehyde to an alcohol effectively abolishes the inhibition.
Aldehyde‐based inhibitors of the peptidoglycan deacetylase Ape were shown to act as competitive inhibitors with Ki values in the low micromolar range. Reduction of the aldehyde to an alcohol abolishes inhibition, suggesting that the binding may involve the formation of a tetrahedral adduct with the active site serine nucleophile. Abstract The O ‐acetylation of the muramic acid residues in peptidoglycan (PG) is a modification that protects the bacteria from lysis due to the action of lysozyme. In Gram‐negative bacteria, deacetylation is required to allow lytic transglycosylases to promote PG cleavage during cell growth and division. This deacetylation is catalyzed by O ‐acetylpeptidoglycan esterase (Ape) which is a serine esterase and employs covalent catalysis via a serine‐linked acyl enzyme intermediate. Loss of Ape activity affects the size and shape of bacteria and dramatically reduces virulence. In this work, we report the first rationally designed aldehyde‐based inhibitors of Ape from Campylobacter jejuni . The most potent of these acts as a competitive inhibitor with a K i value of 13 μM. We suspect that the inhibitors are forming adducts with the active site serine that closely mimic the tetrahedral intermediate of the normal catalytic cycle. Support for this notion is found in the observation that reduction of the aldehyde to an alcohol effectively abolishes the inhibition. The O-acetylation of the muramic acid residues in peptidoglycan (PG) is a modification that protects the bacteria from lysis due to the action of lysozyme. In Gram-negative bacteria, deacetylation is required to allow lytic transglycosylases to promote PG cleavage during cell growth and division. This deacetylation is catalyzed by O-acetylpeptidoglycan esterase (Ape) which is a serine esterase and employs covalent catalysis via a serine-linked acyl enzyme intermediate. Loss of Ape activity affects the size and shape of bacteria and dramatically reduces virulence. In this work, we report the first rationally designed aldehyde-based inhibitors of Ape from Campylobacter jejuni. The most potent of these acts as a competitive inhibitor with a K value of 13 μM. We suspect that the inhibitors are forming adducts with the active site serine that closely mimic the tetrahedral intermediate of the normal catalytic cycle. Support for this notion is found in the observation that reduction of the aldehyde to an alcohol effectively abolishes the inhibition. The O‐acetylation of the muramic acid residues in peptidoglycan (PG) is a modification that protects the bacteria from lysis due to the action of lysozyme. In Gram‐negative bacteria, deacetylation is required to allow lytic transglycosylases to promote PG cleavage during cell growth and division. This deacetylation is catalyzed by O‐acetylpeptidoglycan esterase (Ape) which is a serine esterase and employs covalent catalysis via a serine‐linked acyl enzyme intermediate. Loss of Ape activity affects the size and shape of bacteria and dramatically reduces virulence. In this work, we report the first rationally designed aldehyde‐based inhibitors of Ape from Campylobacter jejuni. The most potent of these acts as a competitive inhibitor with a Ki value of 13 μM. We suspect that the inhibitors are forming adducts with the active site serine that closely mimic the tetrahedral intermediate of the normal catalytic cycle. Support for this notion is found in the observation that reduction of the aldehyde to an alcohol effectively abolishes the inhibition. |
Author | Mahmoodi, Niusha Voskoboinyk, Dmytro Tanner, Martin E. Lin, Chang Sheng‐Huei Murphy, Michael E. P. |
Author_xml | – sequence: 1 givenname: Dmytro surname: Voskoboinyk fullname: Voskoboinyk, Dmytro organization: University of British Columbia – sequence: 2 givenname: Niusha surname: Mahmoodi fullname: Mahmoodi, Niusha organization: University of British Columbia – sequence: 3 givenname: Chang Sheng‐Huei orcidid: 0000-0002-6966-4417 surname: Lin fullname: Lin, Chang Sheng‐Huei organization: University of British Columbia – sequence: 4 givenname: Michael E. P. orcidid: 0000-0003-2589-0014 surname: Murphy fullname: Murphy, Michael E. P. organization: University of British Columbia – sequence: 5 givenname: Martin E. orcidid: 0000-0002-3224-3491 surname: Tanner fullname: Tanner, Martin E. email: mtanner@chem.ubc.ca organization: University of British Columbia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37069132$$D View this record in MEDLINE/PubMed |
BookMark | eNqF0EFLwzAUB_AgE-emV49S8OKlM8lr0_TYFZ2DwTzoubTJq-vo2tp0SG9-BD-jn8SMzQlePOUFfu_P4z8ig6qukJArRieMUn6nskJNOOVgP9Q_IefMg9ANBMDgMHucB0MyMmZNKQ0FsDMyhICKkAE_J7Oo1LjqNX59fE5Tg9qZV6siK7q6NU6dO90KnSdsukLXr2Wv0spZWhkp7PoSTYet3XGiBi_IaZ6WBi8P75i8PNw_x4_uYjmbx9HCVSCk7yoBgZ97kqqM-VJnwDnNNVABPMs9yP0gBPAEYMAgDQPFPK1SqaUWQZhzFcKY3O5zm7Z-29oLkk1hFJZlWmG9NQmXlEspGPUsvflD1_W2rex1VnHGhSc5tWqyV6qtjWkxT5q22KRtnzCa7CpOdhUnx4rtwvUhdpttUB_5T6cWhHvwXpTY_xOXxNN5_Bv-DZM7iTE |
Cites_doi | 10.1016/j.biocel.2007.03.018 10.1074/jbc.M114.567388 10.1021/bi700254m 10.1111/mmi.12153 10.1021/jo102329c 10.1128/IAI.73.9.5697-5705.2005 10.1021/bi051679s 10.1146/annurev-micro-020518-120056 10.3389/fmicb.2018.02332 10.1111/j.1574-6976.2007.00088.x 10.1080/10409238.2017.1337705 10.1021/acs.chemrev.1c00773 10.1002/cbic.201100744 10.1074/jbc.M112.436352 10.1074/jbc.M116.746404 10.1371/journal.ppat.1006512 10.1111/j.1574-6976.2007.00094.x 10.1074/jbc.M110.107086 10.1107/S1399004714016770 10.1006/bioo.1993.1021 |
ContentType | Journal Article |
Copyright | 2023 The Authors. ChemBioChem published by Wiley-VCH GmbH 2023 The Authors. ChemBioChem published by Wiley-VCH GmbH. 2023. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2023 The Authors. ChemBioChem published by Wiley-VCH GmbH – notice: 2023 The Authors. ChemBioChem published by Wiley-VCH GmbH. – notice: 2023. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P WIN CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QL 7QO 7TM 7U9 8FD C1K FR3 H94 K9. M7N P64 7X8 |
DOI | 10.1002/cbic.202300205 |
DatabaseName | Open Access: Wiley-Blackwell Open Access Journals Wiley Free Archive Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Virology and AIDS Abstracts Biotechnology Research Abstracts Technology Research Database Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Nucleic Acids Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Engineering Research Database Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE Virology and AIDS Abstracts |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
EISSN | 1439-7633 |
EndPage | n/a |
ExternalDocumentID | 10_1002_cbic_202300205 37069132 CBIC202300205 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Natural Sciences and Engineering Research Council of Canada (NSERC) – fundername: Canadian Institutes of Health Research (CIHR) funderid: MOP-142176 – fundername: Canadian Institutes of Health Research (CIHR) grantid: MOP-142176 |
GroupedDBID | --- -DZ -~X 05W 0R~ 1L6 1OC 24P 29B 33P 3WU 4.4 4ZD 50Y 5GY 5VS 66C 6J9 6P2 77Q 8-0 8-1 8UM A00 AAESR AAHHS AAIHA AANLZ AAXRX AAZKR ABCUV ABIJN ABJNI ABLJU ACAHQ ACCFJ ACCZN ACGFS ACIWK ACPOU ACPRK ACXBN ACXQS ADBBV ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFRAH AFZJQ AHBTC AHMBA AITYG AIURR AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN AMYDB AZVAB BDRZF BFHJK BMXJE BRXPI CS3 DCZOG DPXWK DR2 DRFUL DRSTM DU5 EBD EBS EMOBN F5P G-S GNP HBH HGLYW HHY HHZ HZ~ IH2 IX1 JPC KQQ LATKE LAW LEEKS LITHE LOXES LUTES LYRES MEWTI MXFUL MXSTM MY~ NNB O9- OIG P2P P2W P4E PQQKQ R.K ROL RWI RX1 SUPJJ SV3 V2E W99 WBKPD WH7 WIN WJL WOHZO WXSBR WYJ XPP XV2 Y6R YZZ ZZTAW ~KM ~S- CGR CUY CVF ECM EIF NPM .GJ 31~ 53G AASGY AAYXX ACBWZ AFFNX AI. ASPBG AVWKF AZFZN CITATION EJD FEDTE GODZA HVGLF VH1 XSW ZGI 7QL 7QO 7TM 7U9 8FD C1K FR3 H94 K9. M7N P64 7X8 |
ID | FETCH-LOGICAL-c3685-c6375f480cb158db3220fd30632bf43f57933463e713a97c14dca8d8d679f2c93 |
IEDL.DBID | 33P |
ISSN | 1439-4227 |
IngestDate | Thu Jul 25 10:58:14 EDT 2024 Thu Oct 10 20:26:12 EDT 2024 Fri Aug 23 03:03:26 EDT 2024 Sat Sep 28 08:14:21 EDT 2024 Sat Aug 24 00:46:22 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | antibiotic N-acetylmuramic acid peptidoglycan reversible covalent inhibitor esterase Campylobacter jejuni |
Language | English |
License | Attribution-NonCommercial 2023 The Authors. ChemBioChem published by Wiley-VCH GmbH. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3685-c6375f480cb158db3220fd30632bf43f57933463e713a97c14dca8d8d679f2c93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-2589-0014 0000-0002-3224-3491 0000-0002-6966-4417 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcbic.202300205 |
PMID | 37069132 |
PQID | 2821264820 |
PQPubID | 986344 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_2802886104 proquest_journals_2821264820 crossref_primary_10_1002_cbic_202300205 pubmed_primary_37069132 wiley_primary_10_1002_cbic_202300205_CBIC202300205 |
PublicationCentury | 2000 |
PublicationDate | June 1, 2023 2023-06-01 2023-06-00 20230601 |
PublicationDateYYYYMMDD | 2023-06-01 |
PublicationDate_xml | – month: 06 year: 2023 text: June 1, 2023 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany – name: Weinheim |
PublicationTitle | Chembiochem : a European journal of chemical biology |
PublicationTitleAlternate | Chembiochem |
PublicationYear | 2023 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2022; 122 2019; 8 2018; 9 2017; 52 2014; 70 2021; 75 2006; 45 2013; 87 2021 1993; 21 2017; 13 2005; 73 2013; 288 2010; 285 2011; 76 2008; 32 2008; 40 2016; 291 2012; 13 2007; 46 2022; 28 2014; 289 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_1_1 e_1_2_7_14_1 e_1_2_7_12_1 e_1_2_7_23_1 e_1_2_7_11_1 e_1_2_7_22_1 e_1_2_7_10_1 e_1_2_7_20_1 Brott A. S. (e_1_2_7_7_1) 2019; 8 Lin C. S. H. (e_1_2_7_13_1) 2021 Vacariu C. M. (e_1_2_7_21_1) 2022; 28 |
References_xml | – volume: 52 start-page: 503 year: 2017 end-page: 542 publication-title: Crit. Rev. Biochem. Mol. Biol. – volume: 75 start-page: 315 year: 2021 end-page: 336 publication-title: Annu. Rev. Microbiol. – volume: 288 start-page: 2605 year: 2013 end-page: 2613 publication-title: J. Biol. Chem. – volume: 32 start-page: 287 year: 2008 end-page: 306 publication-title: FEMS Microbiol. Rev. – volume: 32 start-page: 149 year: 2008 end-page: 167 publication-title: FEBS Microbiol. Rev. – volume: 122 start-page: 8884 year: 2022 end-page: 8910 publication-title: Chem. Rev. – volume: 73 start-page: 5697 year: 2005 end-page: 5705 publication-title: Infect. Immun. – volume: 87 start-page: 1100 year: 2013 end-page: 1112 publication-title: Mol. Microbiol. – volume: 13 year: 2017 publication-title: PLoS Pathog. – volume: 46 start-page: 4932 year: 2007 end-page: 4941 publication-title: Biochemistry – volume: 289 start-page: 16748 year: 2014 end-page: 16760 publication-title: J. Biol. Chem. – volume: 76 start-page: 1118 year: 2011 end-page: 1125 publication-title: J. Org. Chem. – volume: 13 start-page: 722 year: 2012 end-page: 731 publication-title: ChemBioChem – year: 2021 publication-title: bioRxiv – volume: 70 start-page: 2631 year: 2014 end-page: 2639 publication-title: Acta Crystallogr. Sect. D – volume: 28 year: 2022 publication-title: Chem. Eur. J. – volume: 8 year: 2019 publication-title: Antibiotics-Basel. – volume: 21 start-page: 249 year: 1993 end-page: 259 publication-title: Bioorg. Chem. – volume: 291 start-page: 22686 year: 2016 end-page: 22702 publication-title: J. Biol. Chem. – volume: 9 year: 2018 publication-title: Front. Microbiol. – volume: 285 start-page: 13264 year: 2010 end-page: 13273 publication-title: J. Biol. Chem. – volume: 40 start-page: 586 year: 2008 end-page: 591 publication-title: Int. J. Biochem. Cell Biol. – volume: 45 start-page: 839 year: 2006 end-page: 851 publication-title: Biochemistry – ident: e_1_2_7_9_1 doi: 10.1016/j.biocel.2007.03.018 – ident: e_1_2_7_12_1 doi: 10.1074/jbc.M114.567388 – ident: e_1_2_7_15_1 doi: 10.1021/bi700254m – ident: e_1_2_7_18_1 doi: 10.1111/mmi.12153 – year: 2021 ident: e_1_2_7_13_1 publication-title: bioRxiv contributor: fullname: Lin C. S. H. – ident: e_1_2_7_20_1 doi: 10.1021/jo102329c – ident: e_1_2_7_10_1 doi: 10.1128/IAI.73.9.5697-5705.2005 – ident: e_1_2_7_14_1 doi: 10.1021/bi051679s – ident: e_1_2_7_3_1 doi: 10.1146/annurev-micro-020518-120056 – ident: e_1_2_7_6_1 doi: 10.3389/fmicb.2018.02332 – ident: e_1_2_7_5_1 doi: 10.1111/j.1574-6976.2007.00088.x – ident: e_1_2_7_8_1 doi: 10.1080/10409238.2017.1337705 – volume: 28 year: 2022 ident: e_1_2_7_21_1 publication-title: Chem. Eur. J. contributor: fullname: Vacariu C. M. – volume: 8 year: 2019 ident: e_1_2_7_7_1 publication-title: Antibiotics-Basel. contributor: fullname: Brott A. S. – ident: e_1_2_7_1_1 doi: 10.1021/acs.chemrev.1c00773 – ident: e_1_2_7_23_1 doi: 10.1002/cbic.201100744 – ident: e_1_2_7_17_1 doi: 10.1074/jbc.M112.436352 – ident: e_1_2_7_19_1 doi: 10.1074/jbc.M116.746404 – ident: e_1_2_7_4_1 doi: 10.1371/journal.ppat.1006512 – ident: e_1_2_7_2_1 doi: 10.1111/j.1574-6976.2007.00094.x – ident: e_1_2_7_11_1 doi: 10.1074/jbc.M110.107086 – ident: e_1_2_7_16_1 doi: 10.1107/S1399004714016770 – ident: e_1_2_7_22_1 doi: 10.1006/bioo.1993.1021 |
SSID | ssj0009631 |
Score | 2.440143 |
Snippet | The O‐acetylation of the muramic acid residues in peptidoglycan (PG) is a modification that protects the bacteria from lysis due to the action of lysozyme. In... The O-acetylation of the muramic acid residues in peptidoglycan (PG) is a modification that protects the bacteria from lysis due to the action of lysozyme. In... Abstract The O ‐acetylation of the muramic acid residues in peptidoglycan (PG) is a modification that protects the bacteria from lysis due to the action of... |
SourceID | proquest crossref pubmed wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | e202300205 |
SubjectTerms | Acetylation Acetylesterase Adducts Aldehydes Aldehydes - pharmacology Animals antibiotic Bacteria Bacteria - metabolism Campylobacter jejuni Catalysis Deacetylation esterase Esterases - chemistry Gram-negative bacteria Hominidae - metabolism Inhibitors Lysis Lysozyme N-acetylmuramic acid peptidoglycan Peptidoglycan - chemistry Peptidoglycans reversible covalent inhibitor Serine Serine esterase Virulence |
Title | Aldehyde‐Based Inhibitors of the Peptidoglycan O‐Acetylesterase Ape |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcbic.202300205 https://www.ncbi.nlm.nih.gov/pubmed/37069132 https://www.proquest.com/docview/2821264820 https://search.proquest.com/docview/2802886104 |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwEB5BL3AB2gINFGQkVE5RE9vxzzFdWtoLVGorcYviP7rSNlt1u4e99RH6jDwJY2c31aoHJLglip1YM5nMN87MNwCfqbaB-sLktPQ6R3_Nc92akFPeCulaJqSM9c7HZ_L7T_X1MNLkDFX8PT_EsOEWLSN9r6OBt2a2_0Aaas04UhAihEbEE6vMMVRINRzs9IF1V6SGhIgJ4jqoXLE2FnR_ffq6V3oENdeRa3I9Ry__f9Gv4MUSdpK6f0824YnvtmC77jDkvlqQPZISQdMO-xY8G62awG3Dt3ri_OXC-d939wfo8Bw56S7HZhx79JBpIAgfyWlMjHHTX5MFqon8wJG19beLSeJgwDmkvvav4eLo8Hx0nC97L-Q2UtLnVjBZBa4Ka8pKOYN2XwSH8QWjJnAWKrRrxgXzGOS2WtqSO9sqp5yQOlCr2RvY6Kad3wGifNVqwYvgjeZlEMYY4TFqwrspVQmTwZeV7JvrnmKj6cmUaRPl1QzyymB3pZpmaWqzBmPGMqbp0SKDT8NlFFP889F2fjqPYxBGKUSKPIO3vUqHRzFZCI0xeQY0ae4va2hGByej4ezdv0x6D8_jcZ9wtgsbtzdz_wGeztz8Y3p9_wBib-0- |
link.rule.ids | 315,782,786,1408,27935,27936,46066,46490 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB7RcigXHi2UlAJGQnCKmtiOH8d0adkVpVSiSNyi-EVXWrJV2z3sjZ_Ab-SXME42qVYckBDHJHZizXgy39jjbwBeU20D9ZlJae51iv6ap7o2IaW8FtLVTEgZzzuPP8vTr-rdUaTJKfuzMB0_xLDgFi2j_V9HA48L0ge3rKHWTCMHIWJohDzFBtzlgutYvYGxs1veXdGWJERUEEdCZc_bmNGD9f7rfukPsLmOXVvnc_zgPwz7IdxfIU9SdlPlEdzxzTbslA1G3d-X5A1pc0HbRfZt2Br1deB24H05c_5i6fyvHz8P0ec5MmkupmYay_SQeSCIIMlZzI1x82-zJWqKfMKWpfU3y1lLw4B9SHnpH8OX46Pz0ThdlV9IbWSlT61gsghcZdbkhXIGTT8LDkMMRk3gLBRo2owL5jHOrbW0OXe2Vk45IXWgVrMnsNnMG_8UiPJFrQXPgjea50EYY4THwAnfplQhTAJve-FXlx3LRtXxKdMqyqsa5JXAfq-bamVt1xWGjXnM1KNZAq-GxyimuPlRN36-iG0QSSkEizyB3U6nw6eYzITGsDwB2qruL2OoRoeT0XC19y-dXsLW-PzjSXUyOf3wDO7F-13-2T5s3lwt_HPYuHaLF-1c_g1f7PFf |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwEB7RIgEXCi2F0BaMhOAUNbEd_xzTbZeuQGUlQOIWxX90pSW7ot3D3ngEnpEnYZzsplpxqATHJHZizXgy39jjbwBeU20D9ZlJae51iv6ap7o2IaW8FtLVTEgZzzuff5IXX9XpWaTJ6U_xd_wQ_YJbtIz2fx0NfO7C8Q1pqDWTSEGIEBoRT7EFd3nE4vEQBxvf0O6KtiIhgoI4ECrXtI0ZPd7sv-mW_sKam9C19T3Dnf8f9SN4uMKdpOwmymO445td2CsbjLm_L8kb0maCtkvsu3B_sK4Ctwfvyqnzl0vnf__8dYIez5FRczkxk1ikh8wCQfxIxjEzxs2-TZeoJ_IRW5bWXy-nLQkD9iHl3D-BL8Ozz4PzdFV8IbWRkz61gskicJVZkxfKGTT8LDgMMBg1gbNQoGEzLpjHKLfW0ubc2Vo55YTUgVrN9mG7mTX-GRDli1oLngVvNM-DMMYIj2ETvk2pQpgE3q5lX807jo2qY1OmVZRX1csrgcO1aqqVrV1VGDTmMU-PZgm86h-jmOLWR9342SK2QRylECryBJ52Ku0_xWQmNAblCdBWc7eMoRqcjAb91fN_6fQS7o1Ph9WH0cX7A3gQb3fJZ4ewff1j4Y9g68otXrQz-Q-JIfAO |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Aldehyde%E2%80%90Based+Inhibitors+of+the+Peptidoglycan+O%E2%80%90Acetylesterase+Ape&rft.jtitle=Chembiochem+%3A+a+European+journal+of+chemical+biology&rft.au=Voskoboinyk%2C+Dmytro&rft.au=Mahmoodi%2C+Niusha&rft.au=Lin%2C+Chang+Sheng%E2%80%90Huei&rft.au=Murphy%2C+Michael+E.+P.&rft.date=2023-06-01&rft.issn=1439-4227&rft.eissn=1439-7633&rft.volume=24&rft.issue=11&rft.epage=n%2Fa&rft_id=info:doi/10.1002%2Fcbic.202300205&rft.externalDBID=10.1002%252Fcbic.202300205&rft.externalDocID=CBIC202300205 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1439-4227&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1439-4227&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1439-4227&client=summon |